S206: OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF TH... by W. Townsend, W. Hiddemann, C. Buske, G. Cartron, D. Cunningham, M. J. Dyer, J. Gribben, E. Phillips, M. Dreyling, J. F. Seymour, A. Grigg, T.-Y. Lin, X.-N. Hong, D. Kingbiel, T. G. Nielsen, A. Knapp, M. Herold, R. Marcus

Get full text

S220: GLOFITAMAB INDUCES DURABLE COMPLETE REMISSIONS AND HAS FAVORABLE SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA AND ≥2 PRIOR THERAPIES: PIVOTAL PHA... by M. Dickinson, C. Carlo-Stella, F. Morschhauser, E. Bachy, P. Corradini, G. Iacoboni, C. Khan, T. Wróbel, F. Offner, M. Trněný, S.-J. Wu, G. Cartron, M. Hertzberg, A. Sureda, D. Perez-Callejo, L. Lundberg, J. Relf, E. Clark, K. Humphrey, M. Hutchings

Get full text

S210: CAR T-CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-HODGKIN LYMPHOMA: REAL-WORLD STUDY FROM THE DESCAR-T REGISTRY by P. SESQUES, R. DI BLASI, S. LE GOUILL, G. CARTRON, G. MANSON, D. BEAUVAIS, F. LE BRAS, F. X. GROS, S. CHOQUET, P. BORIES, M. T. RUBIO, R. O. CASASNOVAS, L. BOUNAIX, M. MOHTY, M. JORIS, J. ABRAHAM, C. CASTILLA LLORENTE, M. LOSCHI, S. CARRAS, A. CHAUCHET, L. DRIEU LA ROCHELLE, J. ZERBIT, O. HERMINE, S. GUIDEZ, T. GASTINNE, J. J. TUDESQ, P. FOGARTY, F. BROUSSAIS, F. MORSCHHAUSER, R. HOUOT, C. THIEBLEMONT, E. BACHY

Get full text

S260: A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL CAR T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-LIFE LYSA STUDY FROM THE FREN... by E. Bachy, S. Le Gouill, P. Sesques, R. Di Blasi, M. Guillaume, G. Cartron, D. Beauvais, L. Roulin, F. X. Gros, M. T. Rubio, P. Bories, J. O. Bay, C. Castilla Llorente, S. Choquet, R.-O. Casasnovas, M. Mothy, S. Guidez, M. Joris, M. Loschi, S. Carras, J. Abraham, A. Chauchet, L. Drieu La Rochelle, J. Zerbit, O. Hermine, T. Gastinne, J. J. Tudesq, E. Gat, F. Broussais, C. Thieblemont, R. Houot, F. Morschhauser

Get full text

P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE II... by G. Cartron, MD, PhD, E. Bachy, MD, PhD, H. Tilly, MD, N. Daguindau, MD, G.-M. Pica, MD, F. Bijou, MD, C. Mounier, MD, A. M. Clavert, MD, G. L. Damaj, MD, PhD, B. Slama, MD, O. Casasnovas, MD, R. Houot, MD, PhD, K. Bouabdallah, MD, D. Sibon, MD, PhD, O. Fitoussi, MD, N. Morineau, MD, C. Herbaux, MD, PhD, T. Gastinne, MD, L.-M. Fornecker, MD, C. Haioun, MD, PhD, V. Launay, MD, C. Araujo, MD, O. Benbrahim, MD, L. Sanhes, MD, R. Gressin, MD, H. Gonzalez, MD, F. Morschhauser, MD, PhD, L. Xerri, MD, PhD, K. Tarte, PhD, D. Pranger, MD

Get full text